Gaithersburg, Md.-based medical device company Cytomedix (OTC:CMXI) raised $3 million from 10 investors, SEC documents show.
The company plans to use the funds, raised through an offering of debt and options, for general company activity, according to a regulatory filing.
Cytomedix recently touted a reimbursement win from the Centers for Medicare & Medicaid Services for plasma systems, earlier this year. The win included its AutoloGel product and platelet-rich plasma system for patients with chronic ulcers and wounds.
CMXI stock closed last night at 50¢, up 6.4% on the day.